Septal Defect Clinical Trials

16 recruitingLast updated: May 11, 2026

There are 16 actively recruiting septal defect clinical trials across 17 countries. Studies span Not Applicable, Phase 4. Top locations include New York, New York, United States, Beijing, Beijing Municipality, China, Astana, Kazakhstan. Updated daily from ClinicalTrials.gov.


Septal Defect Trials at a Glance

16 actively recruiting trials for septal defect are listed on ClinicalTrialsFinder across 6 cities in 17 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in New York, Beijing, and Astana. Lead sponsors running septal defect studies include Lifetech Scientific (Shenzhen) Co., Ltd., Asan Medical Center, and Alexandria University.

Browse septal defect trials by phase

Treatments under study

About Septal Defect Clinical Trials

Looking for clinical trials for Septal Defect? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Septal Defect trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Septal Defect clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting

Abbott Structural Heart Device Registry

Heart DiseasesValvular Heart DiseasePFO - Patent Foramen Ovale+3 more
Abbott Medical Devices2,500 enrolled28 locationsNCT06590467
Recruiting

A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children

Postoperative ComplicationsCardiac CatheterizationCongenital Heart Disease (CHD)+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine5,249 enrolled1 locationNCT07375602
Recruiting

Pulmonary Embolism and Right-to-Left Shunts

Pulmonary Embolism (PE)StrokePulmonary Arteriovenous Malformation+3 more
Tufts Medical Center256 enrolled1 locationNCT07519876
Recruiting

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

Muscular Ventricular Septal Defect
Occlutech International AB50 enrolled5 locationsNCT05329350
Recruiting
Not Applicable

Investigation of Tetralogy of Fallot in Neonates

Tetralogy of Fallot (TOF)Pulmonary StenosisVentricular Septal Defects (VSD)+1 more
Beijing Anzhen Hospital160 enrolled1 locationNCT06822400
Recruiting

Cerebral Microembolization Associated With PFO Closure

Atrial Septal DefectPatent Foramen Ovale (PFO)Thrombosis Cardiac
China National Center for Cardiovascular Diseases800 enrolled1 locationNCT06347276
Recruiting

Determination of the Frequency and Predictors of Difficult Intubation in Septoplasty Operations

Nasal Septum, IrregularNasal Septal DefectDifficult Endotracheal Intubation+2 more
Başakşehir Çam & Sakura City Hospital300 enrolled1 locationNCT06884592
Recruiting

Mechanical Complications of Acute Myocardial Infarction: a Multicenter Prospective Study

Ventricular Septal DefectPapillary Muscle RuptureCardiac Rupture+1 more
Maastricht University Medical Center800 enrolled1 locationNCT06676345
Recruiting

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

Atrial Septal Defect
Lifetech Scientific (Shenzhen) Co., Ltd.139 enrolled6 locationsNCT06849635
Recruiting
Not Applicable

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Atrial Septal DefectSuccessful Device Closure
Asan Medical Center100 enrolled1 locationNCT02097758
Recruiting

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

Atrial Septal Defect
Lifetech Scientific (Shenzhen) Co., Ltd.145 enrolled7 locationsNCT05887700
Recruiting

Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study

Atrial Septal Defect (ASD)
Lifetech Scientific (Shenzhen) Co., Ltd.100 enrolled5 locationsNCT06700174
Recruiting
Phase 4

Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect

DexmedetomidineDelirium - PostoperativeAtrial Septal Defect (ASD)+1 more
Alexandria University30 enrolled1 locationNCT06631534
Recruiting
Not Applicable

Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?

Allergic RhinitisNasal PolypsNasal Valve Collapse+2 more
Northwell Health96 enrolled3 locationsNCT05287841
Recruiting

Clinical Evaluation Of Ventricular Septal Defect (VSD) In Children at Sohag Univesity Hospital

Ventricular Septal Defect
Sohag University100 enrolled1 locationNCT06492473
Recruiting

Evaluation of the Effectiveness and Safety of Vibro-acoustic Pulmonary Therapy (VAPT) in Complex Therapy for Acute Respiratory Failure of Mixed Type I-II Stages in Comparison With Percussion Massage in Cardiac Surgical Patients in the Early Postoperative Period

Cardiac Surgical Patients (CABG,Mammary Coronary Bypass Surgery,Plastic and Replacement of Valves, Atrial Septal Defect,Ventricular Septal Defect)
Bark Technology LLP310 enrolled5 locationsNCT06320483